Need To Know: Analysts Are Much More Bullish On Galapagos NV (AMS:GLPG) Revenues
Apr 08
Have your own idea? Try our Stock Screener
Dutch (AEX) Healthcare Sector Analysis
UpdatedApr 16, 2026
DataAggregated Company Financials
Companies4
- 7D3.1%
- 3M-5.9%
- 1Y18.6%
- YTD5.3%
Over the last 7 days, the Healthcare industry has risen 6.6%, driven by gains from every company within the industry. In the last 12 months, the industry was up 19%. Looking forward, earnings are forecast to grow by 14% annually.
Sector Valuation and Performance
Has the Dutch Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 16 Apr 2026 | €26.2b | €19.3b | €1.2b | 26.1x | 21.7x | 1.4x |
| Sat, 14 Mar 2026 | €26.0b | €19.3b | €1.2b | 25.8x | 21.5x | 1.3x |
| Mon, 09 Feb 2026 | €26.4b | €18.4b | -€283,031,866.20 | 1516.3x | -93.3x | 1.4x |
| Wed, 07 Jan 2026 | €26.1b | €18.4b | -€283,028,160.80 | 1561.9x | -92.3x | 1.4x |
| Fri, 05 Dec 2025 | €24.4b | €18.4b | -€283,027,320.40 | 1545.9x | -86.3x | 1.3x |
| Sun, 02 Nov 2025 | €25.2b | €18.4b | -€138,044,500.00 | 132.7x | -182.6x | 1.4x |
| Tue, 30 Sep 2025 | €24.6b | €18.4b | -€137,923,140.00 | 128.7x | -178.7x | 1.3x |
| Thu, 28 Aug 2025 | €25.4b | €18.4b | -€146,067,360.00 | 133.1x | -173.7x | 1.4x |
| Sat, 26 Jul 2025 | €23.4b | €18.5b | -€83,064,956.80 | 88.1x | -281.5x | 1.3x |
| Mon, 23 Jun 2025 | €21.0b | €18.5b | €25.8m | 78.8x | 811.8x | 1.1x |
| Wed, 21 May 2025 | €22.1b | €18.6b | €25.6m | 82.9x | 862.9x | 1.2x |
| Fri, 18 Apr 2025 | €21.3b | €18.6b | -€855,692,607.20 | n/a | -24.9x | 1.1x |
| Sun, 16 Mar 2025 | €24.7b | €18.6b | -€855,414,710.30 | n/a | -28.9x | 1.3x |
| Tue, 11 Feb 2025 | €27.0b | €18.6b | -€608,672,492.32 | n/a | -44.4x | 1.5x |
| Thu, 09 Jan 2025 | €25.5b | €18.6b | -€608,527,946.30 | n/a | -41.9x | 1.4x |
| Sat, 07 Dec 2024 | €25.5b | €18.6b | -€608,483,737.69 | n/a | -41.8x | 1.4x |
| Mon, 04 Nov 2024 | €25.2b | €18.6b | -€607,351,920.08 | n/a | -41.4x | 1.4x |
| Wed, 02 Oct 2024 | €29.8b | €18.7b | -€597,213,370.15 | 53.7x | -49.9x | 1.6x |
| Fri, 30 Aug 2024 | €28.0b | €18.7b | -€610,799,952.55 | 56.1x | -45.8x | 1.5x |
| Sun, 28 Jul 2024 | €24.4b | €18.6b | -€848,301,328.30 | 53.9x | -28.8x | 1.3x |
| Tue, 25 Jun 2024 | €25.1b | €18.6b | -€848,199,917.67 | 52.2x | -29.6x | 1.3x |
| Thu, 23 May 2024 | €26.1b | €18.6b | -€847,667,837.97 | 56.1x | -30.7x | 1.4x |
| Sat, 20 Apr 2024 | €19.6b | €18.6b | -€570,172,047.42 | n/a | -34.4x | 1.1x |
| Mon, 18 Mar 2024 | €20.4b | €18.6b | -€565,049,938.53 | n/a | -36.1x | 1.1x |
| Wed, 14 Feb 2024 | €20.5b | €18.9b | -€725,758,443.96 | n/a | -28.2x | 1.1x |
| Fri, 12 Jan 2024 | €23.5b | €19.3b | -€877,516,610.00 | n/a | -26.7x | 1.2x |
| Sun, 10 Dec 2023 | €20.6b | €19.3b | -€878,068,074.00 | n/a | -23.5x | 1.1x |
| Tue, 07 Nov 2023 | €20.6b | €19.3b | -€877,361,858.00 | n/a | -23.4x | 1.1x |
| Thu, 05 Oct 2023 | €20.7b | €19.1b | -€2,302,877,117.00 | n/a | -9x | 1.1x |
| Sat, 02 Sep 2023 | €22.3b | €19.1b | -€2,427,019,514.00 | n/a | -9.2x | 1.2x |
| Mon, 31 Jul 2023 | €21.2b | €19.1b | -€2,437,623,662.00 | n/a | -8.7x | 1.1x |
| Wed, 28 Jun 2023 | €21.0b | €18.8b | -€2,534,089,774.00 | n/a | -8.3x | 1.1x |
| Fri, 26 May 2023 | €20.1b | €18.8b | -€2,531,926,373.00 | n/a | -7.9x | 1.1x |
| Sun, 23 Apr 2023 | €18.8b | €18.5b | -€2,040,395,819.00 | 51.4x | -9.2x | 1x |
Price to Earnings Ratio
-9.2x
Current Industry PE
- Investors are optimistic on the Dutch Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 21.8x which is higher than its 3-year average PE of 18.5x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable.
- Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare sector?
| NL Market | 1.14% | |
| Healthcare | 3.10% | |
| Medical Equipment | 3.26% | |
| Biotech | 1.73% | |
| Pharma | 0% | 0 |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 11.1x.
- Analysts are expecting annual earnings growth of 16.3% and investors are willing to pay a premium for that growth.
- Investors are most pessimistic about the Biotech industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 16% over the next 5 years.
- In contrast, the Biotech industry is expected to see its earnings decline by 7.5% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIA Koninklijke Philips | €24.68 | 2.9% +€656.4m | 17.9% | PE26.1x | |
| PHARM Pharming Group | €1.49 | 2.2% +€22.2m | 112.6% | PE434.8x | |
| GLPG Galapagos | €24.46 | 0.3% +€5.3m | 12.0% | PE5x | |
| VVY Vivoryon Therapeutics | €1.34 | 1.5% +€592.3k | -23.5% | PB12.5x |